Systematic Reviews and Meta-and Pooled Analyses Soy Food Intake and Risk of Lung Cancer : Evidence From the Shanghai Women ’ s Health Study and a Meta-Analysis

The authors prospectively evaluated the association of soy food intake with lung cancer risk, overall and by tumor aggressiveness, and performed a meta-analysis of published data. Included in the analysis were 71,550 women recruited into the Shanghai Women’s Health Study (Shanghai, China) in 1997–2000. Usual soy food intake was assessed at baseline and reassessed during follow-up through in-person interviews. During a mean follow-up period of 9.1 years, 370 incident lung cancer cases were identified; 340 patients were lifetime never smokers. After adjustment for potential confounders, soy food intake was inversely associated with subsequent risk of lung cancer (Ptrend = 0.004); the hazard ratio for the highest quintile of intake compared with the lowest was 0.63 (95% confidence interval: 0.44, 0.90). This inverse association appeared predominately among women with later age at menopause (Pinteraction = 0.01) and for aggressive lung cancer as defined by length of survival (<12 months vs. ≥12 months; Pheterogeneity = 0.057). Meta-analysis of 7 studies conducted among nonsmokers found a summary relative risk of 0.59 (95% confidence interval: 0.49, 0.71) for the highest categories of soy or isoflavone intake versus the lowest. This study suggests that soy food consumption may reduce lung cancer risk in nonsmoking women, particularly for aggressive tumors, and its effect may be modified by endogenous estrogens.

[1]  G. Vlastos,et al.  Lung cancer mortality risk among breast cancer patients treated with anti‐estrogens , 2011, Cancer.

[2]  M. Inoue,et al.  Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. , 2010, The American journal of clinical nutrition.

[3]  G. Vlastos,et al.  Reduced Lung Cancer Mortality Risk among Breast Cancer Patients Treated with Anti-Estrogens. , 2009 .

[4]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[5]  J. Manson,et al.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial , 2009, The Lancet.

[6]  N. Rothman,et al.  Occupational risk of lung cancer among lifetime non-smoking women in Shanghai, China , 2009, Occupational and Environmental Medicine.

[7]  R. Levy,et al.  The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. , 2009, Nutrition reviews.

[8]  W. Koh,et al.  Reproductive Variables, Soy Intake, and Lung Cancer Risk among Nonsmoking Women in the Singapore Chinese Health Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[9]  X. Shu,et al.  Prospective cohort study of soy food intake and colorectal cancer risk in women. , 2009, The American journal of clinical nutrition.

[10]  M. Berhow,et al.  Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages. , 2008, Journal of agricultural and food chemistry.

[11]  K. Cao,et al.  Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  D. Jacobs,et al.  Dietary flavonoid intake and risk of cancer in postmenopausal women: The Iowa Women's Health Study , 2008, International journal of cancer.

[13]  G. Scambia,et al.  Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice. , 2008, The Journal of nutrition.

[14]  R. Mehta,et al.  Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. , 2007, Cancer research.

[15]  A. Partridge,et al.  Implications of Phytoestrogen Intake for Breast Cancer , 2007, CA: a cancer journal for clinicians.

[16]  M. Heinonen,et al.  Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-κB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-κB Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated , 2007, Mediators of inflammation.

[17]  X. Shu,et al.  A Prospective Study of Dietary Patterns and Mortality in Chinese Women , 2007, Epidemiology.

[18]  X. Shu,et al.  Assessment of dietary isoflavone intake among middle-aged Chinese men. , 2007, The Journal of nutrition.

[19]  S. H. Lee,et al.  Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentration , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  W. McCaskill-Stevens,et al.  Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. , 2006, Journal of the National Cancer Institute.

[21]  H. Nelson,et al.  Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. , 2006, Archives of internal medicine.

[22]  L. Fournier,et al.  Soy isoflavones modulate immune function in healthy postmenopausal women. , 2006, The American journal of clinical nutrition.

[23]  M. Fishbein,et al.  Aromatase inhibitors in human lung cancer therapy. , 2005, Cancer research.

[24]  N. Rothman,et al.  The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.

[25]  D. Gjertson,et al.  Does duration of donor brain injury affect outcome after orthotopic pediatric heart transplantation? , 2005, The Journal of thoracic and cardiovascular surgery.

[26]  M. Spitz,et al.  Dietary phytoestrogens and lung cancer risk. , 2005, JAMA.

[27]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[28]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[29]  L. Hartmann,et al.  Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. , 2003, The New England journal of medicine.

[30]  Heidi D Nelson,et al.  Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.

[31]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[32]  M. Teh,et al.  Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: Evidence for a protective effect of soy in nonsmokers , 2002, International journal of cancer.

[33]  Y. Yatabe,et al.  Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas , 2001, British Journal of Cancer.

[34]  A. Tamakoshi,et al.  Risk modification in lung cancer by a dietary intake of preserved foods and soyfoods: findings from a case-control study in Okinawa, Japan. , 1999, Lung cancer.

[35]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[36]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[37]  Kenneth C Johnson,et al.  A case‐control study of diet and lung cancer in Northeast China , 1997 .

[38]  W. Mazur,et al.  Phyto-oestrogens and Western diseases. , 1997, Annals of medicine.

[39]  C. Haslett,et al.  Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. , 1996, Cancer research.

[40]  S Greenland,et al.  Meta‐analysis of Epidemiologic Dose‐Response Data , 1993, Epidemiology.

[41]  Y. Lee,et al.  Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene. , 1991, Journal of Korean medical science.

[42]  W. Blot,et al.  Lung cancer among women in north-east China. , 1990, British Journal of Cancer.

[43]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[44]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[45]  W. Mcgregor,et al.  Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. , 2006, Endocrine-related cancer.

[46]  X. Shu,et al.  Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study , 2004, European Journal of Clinical Nutrition.

[47]  J. Sterne,et al.  How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. , 2003, Health technology assessment.

[48]  J. Luketich,et al.  Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. , 2002, Cancer research.

[49]  P. Eilers,et al.  Non-proportional hazards models in survival analysis , 2000 .

[50]  Yiwei Li,et al.  p53-independent apoptosis induced by genistein in lung cancer cells. , 1999, Nutrition and cancer.

[51]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[52]  M. Nair,et al.  Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. , 1998, Nutrition and cancer.

[53]  J. Corton,et al.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.

[54]  Yiwei Li,et al.  Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. , 1998, Nutrition and cancer.

[55]  W. D. Ray.  4. Modelling Survival Data in Medical Research , 1995 .

[56]  L. Koo.  Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked. , 1988, Nutrition and cancer.